Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trials

被引：0
|
作者：
Hongmei Zhu
Shuang Zhu
Xiuqian Zhang
Yang Guo
Yunzhen Shi
Zhimin Chen
Siu-wai Leung
机构：
[1] University of Macau,State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences
[2] University of Edinburgh,School of Informatics
来源：
Diabetology & Metabolic Syndrome | / 5卷
关键词：
Glimepiride; Metformin; Type 2 diabetes mellitus; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trials
    Zhu, Hongmei
    Zhu, Shuang
    Zhang, Xiuqian
    Guo, Yang
    Shi, Yunzhen
    Chen, Zhimin
    Leung, Siu-wai
    DIABETOLOGY & METABOLIC SYNDROME, 2013, 5
  • [2] Efficacy and safety of dapagliflozin as monotherapy in patients with type 2 diabetes mellitus A meta-analysis of randomized controlled trials
    Feng, Miao
    Lv, Haihong
    Xu, Xia
    Wang, Jue
    Lyu, Wenyi
    Fu, Songbo
    MEDICINE, 2019, 98 (30)
  • [3] Effect of Metformin on Lipid Profiles of Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials
    Gillani, Syed Wasif
    Ghayedi, Nahal
    Roosta, Pardis
    Seddigh, Parvin
    Nasiri, Omaimah
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2021, 13 (01) : 76 - 82
  • [4] Efficacy and safety of empagliflozin for type 2 diabetes mellitus Meta-analysis of randomized controlled trials
    Zhang, Yun-Jing
    Han, Shi-Liang
    Sun, Xi-Feng
    Wang, Shu-Xiang
    Wang, Hong-Yun
    Liu, Xiao
    Chen, Li
    Xia, Ling
    MEDICINE, 2018, 97 (43)
  • [5] Longitudinal efficacy of Ertugliflozin in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
    Khan, Parvej
    Venkatesh, Shubhashree
    Parveen, Rizwana
    Mishra, Pinki
    Jain, Seema
    Agarwal, Nidhi
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2199 - 2210
  • [6] Efficacy and safety of empagliflozin in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
    Devi, R.
    Mali, Ghanshyam
    Chakraborty, Indrani
    Unnikrishnan, Mazhuvancherry Kesavan
    Abdulsalim, Suhaj
    POSTGRADUATE MEDICINE, 2017, 129 (03) : 382 - 392
  • [7] SAFETY AND EFFICACY OF SITAGLIPTIN COMPARED WITH GLIMEPIRIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED WITH METFORMIN MONOTHERAPY
    Abrar, Amjad
    Khan, Shimal
    Rehman, Mehboob Ur
    Jan, Tehmina
    Faisal, Muhammad
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2013, 11 (01): : 3 - 7
  • [8] EFFICACY AND SAFETY OF DULAGLUTIDE IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Kanukula, R.
    Likhar, N.
    Mothe, R. K.
    Dang, A.
    VALUE IN HEALTH, 2016, 19 (03) : A198 - A199
  • [9] Metformin Plus A Low Hypoglycemic Risk Antidiabetic Drug vs. Metformin Monotherapy for Untreated Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
    Hung, Wei-Tse
    Hsu, Chia-Yu
    Lee, Meng
    Cheng, Chun-Yu
    Ovbiagele, Bruce
    Chen, Yuan-Jung
    CEREBROVASCULAR DISEASES, 2022, 51 (SUPPL 1) : 60 - 61
  • [10] Metformin plus a low hypoglycemic risk antidiabetic drug vs. metformin monotherapy for untreated type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
    Hung, Wei-Tse
    Chen, Yuan-Jung
    Cheng, Chun-Yu
    Ovbiagele, Bruce
    Lee, Meng
    Hsu, Chia-Yu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 189
12345